Clinical Trials
2 trialsNCT03275402 2024-02-13
131I-omburtamab Radioimmunotherapy for Neuroblastoma Central Nervous System/Leptomeningeal Metastases
Y-mAbs Therapeutics
Phase 2/3 Terminated
NCT00539500 2019-07-26
Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma
M.D. Anderson Cancer Center
Phase 2/3 Terminated